Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Intrexon Corp (NYSE:XON)

24.38
Delayed Data
As of 3:52pm ET
 +0.37 / +1.54%
Today’s Change
18.52
Today|||52-Week Range
69.45
-19.14%
Year-to-Date
Intrexon's Genetically Engineered Mosquitoes (Finally) Have Data. What's Next?
Jul 21 / MotleyFool.com - Paid Partner Content
ZIOPHARM (ZIOP) Stock Down on Patient Death in Phase I
Jul 18 / Zacks.com - Paid Partner Content
13 Companies to Watch From MIT's Smart 50 List, Including 4 Buys
Jul 21 / TheStreet.com - Paid Partner Content
This Farming Tool Is Failing. Can Intrexon Bail Out an Industry?
Jul 13 / MotleyFool.com - Paid Partner Content
Intrexon (XON) Marked As A Dead Cat Bounce Stock
Jul 20 / TheStreet.com - Paid Partner Content
Here's Why Ziopharm Oncology, Inc. Shares Took a Pounding and Lost 30% in June
Jul 11 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close24.01
Today’s open24.03
Day’s range23.87 - 24.59
Volume773,845
Average volume (3 months)1,973,870
Market cap$2.8B
Dividend yield--
Data as of 3:52pm ET, 07/25/2016

Growth & Valuation

Earnings growth (last year)+8.43%
Earnings growth (this year)-73.52%
Earnings growth (next 5 years)-78.25%
Revenue growth (last year)+141.35%
P/E ratioNM
Price/Sales19.29
Price/Book4.04

Competitors

 Today’s
change
Today’s
% change
CTLTCatalent Inc+0.23+0.95%
JUNOJuno Therapeutics In...+0.10+0.33%
KITEKite Pharma Inc+0.70+1.38%
OPHTOphthotech Corp-0.88-1.37%
Data as of 3:52pm ET, 07/25/2016

Financials

Next reporting dateAugust 11, 2016
EPS forecast (this quarter)-$0.26
Annual revenue (last year)$173.6M
Annual profit (last year)-$84.5M
Net profit margin-48.67%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Randal J. Kirk
President
Geno J. Germano
Corporate headquarters
Germantown, Maryland

Forecasts

Partner Offers

Search for Jobs